RAD51 and cancer: Moreover, it was shown that the survival of cancer patients expressing higher levels of RAD51 is shorter and that a reduced amount of RAD51 in the cellular model, following antisense or ribozyme treatment, increases the effectiveness of cancer treatment by radiotherapy [16,17,18].